Consultant services for pharma and biotech from development to Marketing Authorisation

Pre-Approval solutions

Science and business go hand in hand. We support your product development with the end goal of market entry in mind. Regulatory compliance is key for building a strong business case in pharma and biotech.

Our cross-functional team of experts offer guidance and support for compliance across regulatory affairs, quality assurance and safety.

Speak the language of Marketing Approval

Accelerate your path to approval

Build your MAA strategy for clarity, quality, and success. Our experienced team has a proven track-record of successful preparation and management of Marketing Authorisation Applications.

Regulatory Affairs & CMC

With the right expertise in regulatory affairs and CMC, complex requirements are transformed  into clear, manageable development pathways. Experienced guidance helps you anticipate challenges, as well as design compliant and efficient development strategies. Ultimately bringing innovative therapies to patients.

Quality Assurance

Experienced quality assurance specialists translate complex requirements into practical, efficient quality systems that support development rather than slow it down. Their expertise helps you establish the right processes, documentation, and oversight from the outset, reducing compliance risks and preventing costly delays.

Launch readiness expertise

Whether you are planning to market your product after approval, or to divest it, your strategy should include a market access perspective. Early alignment of commercial strategy with regulatory and clinical development, will help you optimise pricing outcomes and patient access. 

Key services in early phase pharma

Our cross-functional team of experts offer strategic advice and operational excellence across regulatory affairs, quality assurance and pharmacovigilance. With a joint perspective of compliance and commercial competitiveness, we support your journey from development to approval.

Regulatory strategies

  • Regulatory strategy plan
  • Scientific advice
  • Target Product Profile (TPP)
  • Quality Target Product Profile (QTPP)
  • Risk assessment

Regulatory pathways

  • Regulatory timelines
  • Orphan Drug Designation
  • Pediatric Investigational Plan (PIP)
  • PRIME designation

Regulatory support

  • Project management
  • Documentation management
  • Publishing support
  • Agency interactions

Clinical trials

  • Clinical and product development
  • IMPD writing
  • Medical writing
  • IMP labelling
  • CTIS submission

CMC strategy and support

  • CMC development plan 
  • Formulation development strategy
  • Analytical method validation advice
  • Impurity profile and spec limits
  • Tech transfer support
  • Combination product development

Early market access

  • Landscape review
  • Unmet need
  • Market potential

Investor/Exit strategies

  • Due diligence readiness
  • Gap analysis
  • Supply chain robustness
  • Quality data room setup and maintenance
  • Workstream leads

QA support

  • Validation/qualification
  • Document management systems
  • Self-inspections
  • Acting QP services

Supplier management

  • Audits (GMP, GLP, GDP)
  • Quality agreements
  • Tech transfer support

Training

  • GXP overview
  • GMP (in depth)
  • GLP (in depth)
  • GDP (in depth)

QMS

  • SOP writing
  • Offer for small startups: Small efficient fit-for-purpose QMS
Your contact person

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.